Cytophagic histiocytic panniculitis: is it a macrophage activation syndrome in situ?
- PDF / 98,086 Bytes
- 1 Pages / 595.28 x 793.7 pts Page_size
- 9 Downloads / 243 Views
POSTER PRESENTATION
Open Access
Cytophagic histiocytic panniculitis: is it a macrophage activation syndrome in situ? B Bader-Meunier1*, S Fraitag2, CEI Janssen3, G de Saint Basile4, K Brochard5, N Brousse2, C Bodemer6, C Wouters7 From 18th Pediatric Rheumatology European Society (PReS) Congress Bruges, Belgium. 14-18 September 2011 Background Cytophagic histiocytic panniculitis (CHP) is a rare lobular panniculitis, characterized by subcutaneous proliferation of benign-appearing cytophagic histiocytes and lymphocytes often associated with systemic macrophage activation syndrome (MAS). Its pathogenesis is unknown. Aim To report on immunohistochemical findings on skin CHP tissue. Patients A 10-month-old year boy and a 4-month-old-year girl presented with multiple erythematous and indurated noduless on the limbs, and developed high-grade fever and biological features suggestive of MAS several months after the onset of cutaneous disease. Serologic test for EBV was negative and bone marrow examination revealed hemophagocytosis. A homozygous splicing mutation for the UNC13D gene encoding for Munc 13-4 was present in patient 1, but NK cell cytotoxicity and degranulation assays, and expression of Munc 13-4 protein were normal. No mutation was found in Patient 2. Prednisone alone failed to induce a sustained remission which was obtained by adding cyclosporine A. Results Skin biopsy specimen revealed a lobular panniculitis with areas of necrosis in both patients. The inflammatory infiltrate consisted of lymphocytes and macrophages in dermis and hypodermis, and signs of hemophagocytosis. There were no atypical cells. These findings were consistent with CHP. Immunohistochemical stainings showed * Correspondence: [email protected] 1 Department of Pediatrics, Paris, France Full list of author information is available at the end of the article
numerous CD68 macrophages and CD8+lymphocytes, expressing HLA-DR, and a few CD4+ cells. Lymphocytes expressed IFN-g and macrophages TNF-a and IL6. These immunohistochemical features were characteristic of MAS.
Conclusion This study provides evidence that CHP may represent MAS in situ in adipose tissue; and emphasized that CHP can precede systemic signs of MAS by several months. Author details 1 Department of Pediatrics, Paris, France. 2Department of Pathology, Paris, France. 3Department of Pathology, Leuven, Belgium. 4INSERM U 768, Paris France. 5Department of Pediatrics, Toulouse, France. 6Department of Dermatology, Paris, France. 7Department of Pediatrics, Leuven, Belgium. Published: 14 September 2011
doi:10.1186/1546-0096-9-S1-P308 Cite this article as: Bader-Meunier et al.: Cytophagic histiocytic panniculitis: is it a macrophage activation syndrome in situ? Pediatric Rheumatology 2011 9(Suppl 1):P308.
Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar •
Data Loading...
